Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jingqianshu
- Development stage
- Phase 4
- Lead developer
- Qinhuangdao Shanhaiguan Pharmaceutical
- Administration
- Oral
01
Overview
Jingqianshu is a Traditional Chinese Medicine (TCM) formulation, typically administered as granules, developed for the treatment of premenstrual syndrome (PMS). Developed by the Hebei University of Traditional Chinese Medicine, the drug is currently undergoing clinical evaluation to confirm its efficacy and safety in managing the physical and emotional symptoms associated with the premenstrual phase. As a botanical product, its therapeutic effect is attributed to the synergistic action of its constituent herbal extracts, which are traditionally used in Chinese medicine to regulate qi and soothe the liver, thereby addressing the underlying imbalances thought to cause PMS symptoms.
- Brand names
- Jingqianshu
- Other names
- Jingqianshu granules
02
Targets
HCRTR1 (Orexin/hypocretin receptor type 1)HCRTR2 (Orexin/hypocretin receptor type 2)
Beyond the preview
Go deeper on Jingqianshu.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jingqianshu.